Chang Gong

机构：Sun Yat-sen University, Sun Yat-sen Memorial Hospital · ORCID：0000-0001-5215-7497

发表论文 110 篇 · 总被引 8062 次 · h-index 35

代表论文

• Dynamic ctDNA tracking stratifies relapse risk for triple negative breast cancer patients receiving neoadjuvant chemotherapy (2025 · Nature Communications · 被引 24)
• Deep learning combining mammography and ultrasound images to predict the malignancy of BI-RADS US 4A lesions in women with dense breasts: a diagnostic study (2024 · International Journal of Surgery · 被引 20)
• Targeting autophagy plus high-dose CDK4/6 inhibitors in advanced HR+HER2− breast cancer: A phase 1b/2 trial (2024 · Med · 被引 14)
• Preclinical study and phase 2 trial of neoadjuvant pyrotinib combined with chemotherapy in luminal/HER2-low breast cancer: PILHLE-001 study (2024 · Cell Reports Medicine · 被引 7)
• Association between Homologous Recombination Repair Defect Status and Long-Term Prognosis of Early HER2-Low Breast Cancer: A Retrospective Cohort Study (2024 · The Oncologist · 被引 6)
• Effect of methylcobalamin on capecitabine induced hand-foot syndrome in patients with HER2 negative early breast cancer: multicentre, double blind, randomised, placebo controlled, phase 3 trial (2025 · BMJ · 被引 4)